Compare Liquidia Corporation Common Stock (LQDA) vs TTM Technologies Inc. Common Stock (TTMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs TTM Technologies Inc. Common Stock — how do they compare? Liquidia Corporation Common Stock trades at $34 (market cap $3.04B), while TTM Technologies Inc. Common Stock trades at $99.5 (market cap $10.87B). The key difference: TTM Technologies Inc. Common Stock is far larger — about 3.6× Liquidia Corporation Common Stock's market cap, and Liquidia Corporation Common Stock is more actively traded (21,111,778 versus 4,290,307). Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and TTM Technologies Inc. Common Stock for 2 Days on average.
| LQDA | TTMI | |
|---|---|---|
Market Cap | $3.04B | $10.87B |
Volume | 21,111,778 | 4,290,307 |
Sector | Health | Technology |
52-Week High | $91.03 | $221.47 |
52-Week Low | $22.02 | $55.69 |
Typical Hold Time | 0 Days | 2 Days |
Enterprise Value | $2.94B | $11.47B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TTMI trades at $116.10, up 5.23% today, but faces a bearish technical signal. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Strong revenue growth is projected, from $2.9B in 2025 to $3.4B in 2026, alongside a rising net profit margin. A significant $1.7B defense backlog and expansion in AI data-center demand support the growth narrative, though the stock's valuation multiples appear elevated.
The outlook is mixed; robust fundamentals and overwhelming analyst buy ratings (85.7%) suggest long-term potential, with a consensus price target of $203.67 implying substantial upside. However, near-term technical weakness and high valuation ratios relative to profitability metrics present risks, requiring careful monitoring of execution against growth expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About TTM Technologies Inc. Common Stock
TTM Technologies manufactures printed circuit boards, radio-frequency components, and electronics assemblies. Its products are used in aerospace, defense, automotive, data center, and communications equipment.
Read more on TTMI →
